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ABSTRACT
The interruption of DNA binding is a gateway to the inhibition of unregulated
expression of genes which can possibly lead to illnesses such as cancer and epilepsy. The
goal of this research is to produce high affinity DNA binding molecules which could act
to displace the binding of natural transcription factor thus reducing the over- or underexpression of various proteins. Literature shows that the interruption of DNA binding can
be completed using both organic and inorganic means, such as by means of natural
transcription factors like the NF-κB protein or with metal-ligand complexes in order to
bind DNA. NF-κB, a protein that plays a vital role in cell growth and immune response,
works as a transcription factor and binds DNA using a beta sheet loop region. Mimics of
the NF-κB binding region will be made and analyzed via circular dichroism and
fluorescence. Metal ligand complexes are able to bind to DNA through two different
interactions: intercalation into DNA via the ligand portion and ion coordination with the
negatively charged phosphate backbones of DNA. The analysis of the metal complex
binding affinity will be done using UV-Vis fluorescence spectroscopy, circular dichroism
(CD) studies, and gel electrophoresis assays. The overall purpose of this research is to
identify the more efficient binder with the higher affinity for DNA binding between
organic and inorganic molecules.
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Introduction
The disruption of DNA binding is a gateway to the inhibition of expression of
harmful genes which can possibly lead to illnesses such as cancer and epilepsy and as a
result, artificial control of gene expression has been of interest in the medical field.6 The
goal of this research is to achieve results, which could possibly lead to a better
understanding of how DNA binds and eventually preventing binding in harmful strands.
Literature shows that the interrupting of DNA binding can be done using both organic
and inorganic means, such as using natural transcription factors like the NF-κB protein or
using metals in complexes with ligand in order to bind DNA.6 In this research, the
difference in affinity for DNA binding between organic and inorganic compounds will be
compared and the more efficient binder will be the main focus of research.
NF-κB is an important protein that plays a
vital role in cell growth and immune response.3
Working as a transcription factor, the protein binds
directly to DNA and helps control the levels of
transcription, thus gene expression. When the
regulation of NF-κB is flawed, links to illnesses
Figure 1. The binding of
DNA via NF-κB. The figure
depicts the two subunit in
conjunction around the DNA
while the β-hairpin region
binds the DNA.3

such as carcinogenesis and epilepsy have been
discovered.7 The portion of the protein that makes
the binding possible is the β-hairpin, or beta sheet
loop region.3 The binding of the β-hairpin can be

mimicked so that the binding is similar to that of the original β-hairpin but its purpose
would be to block the binding of harmful DNA. A mimic of the structured β-hairpin
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found in the NF-κB will be used in binding studies such as fluorescence techniques like
tryptophan quenching and could be completed in order to compare the binding affinity of
the mimic to that of the original protein. The results of this experiment should analyze the
ability of the mimic peptides to bind DNA as compared to NF-κB. Overall, if either
mimic peptide is more successful in binding DNA than NF-κB, then the research could
potentially be used in a clinical setting in order to prevent the overexpression of particular
genes implicated in various diseases.
Metal ligand complexes are becoming well studied
molecules in the disruption of DNA binding. In fact, this
technique has already been used in cancer treatment in
which drugs such as cisplatin, which contains platinum,
binds and damages DNA in order to prevent cell
division.4 Metal ligand complexes are able to bind to
DNA through two different interactions. The ligand
portion has a planar heterocyclic structure and the
aromatic portion is able to intercalate into the DNA, while
the metal portion binds through ion coordination with the
negatively charged phosphate backbones of DNA.1 For the

Figure 2. The binding of
DNA via Metal-Ligand
Complex. The figure depicts
the ligand intercalating into the
DNA, while the metal interacts
with the phosphate backbone.2

focus of this research, metals of the lanthanides series will
be used as the metal with ligand complexes, because they have been a recent interest due
to their cytotoxicity as compared to drugs like cisplatin which use metals such as
platinum.4 The analysis of the metal complexes’ binding affinities will be completed
using circular dichroism (CD) studies and gel electrophoresis assays in which the
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expectation is that there will be a conformational change in the DNA as the metal-ligand
complex binds the DNA. Multiple lanthanide metals will be used in order to determine
the one with the highest binding affinity.
Overall, the goal of this research is to determine the binding affinity of the
synthesized DNA binding molecules, with the goal that they will have a higher affinity
and displace natural transcription factors. If successful, this research could be used in
order to prevent the over- or under-expression of genes by these transcription factors.

Methods
Peptide Design

Figure 3. NF-κB Hybrid Structure. The sequence for the peptide mimic was based on the
binding site of the original NF-κB protein and is as follows:
Gln-Arg-Phe-Arg-Trp-Val-Arg-Val-Asn-Gly-Lys-Tyr-Ile-Lys-Val-Gln-Leu-Glu
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Metal-Ligand Complexes

Figure 4. Gd-Ligand Complex. The molecular formula is as follows:
[Gd III (NO3)2 (H2O) (pyr)2]. The other complexes (Tb, Dy, Er, and Ho) have the same
structure with the central metal atom being varied for each.

Peptide Synthesis
For each peptide, CLEAR amide resin was employed to synthesize the peptide
using a 0.1 mmol scale, with each amino acid coupled onto the resin with four
equivalents of HBTU, a coupling reagent. Dimethylformamide was the solvent for all
peptide synthesis. A 20% piperidine solution in DMF was utilized to deprotect the Fmoc
protecting group from each amino acid. Coupling times of about 60 minutes and
deprotection times of 20 minutes were employed. The order sequence was then run in a
Protein Technologies PS3 peptide synthesizer coupling from the C terminal to the N
terminal amino acid. The last eight amino acids were double coupled and an acetic
anhydride capping solution was added to cap the N-terminal of the peptide.
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Cleavage
In order to cleavage the peptide from the resin on which it was synthesized, a
cleavage reaction had to be conducted. To dry the resin, dichloromethane was used along
with nitrogen gas to agitate the sample. The cleavage cocktail was composed of 95%
trifluoroacetic acid (TFA), 2.5% tri-isopropalsilane (TIPS), and 2.5 water, and this was
allowed to react with the peptide in a cleavage flask for two hours. The resulting solution
was then drained into a round bottom flask which was then treated with air until enough
TFA had evaporated and only a dime-sized amount remained. Then 20 mL of ether and
20 mL of water was added to the flask in order to allow the peptide to precipitate out of
the solution. The final solution was then allowed to separate in a separatory funnel. The
various layers were collected then frozen in liquid nitrogen, followed by three days on the
lyophilizer, resulting in peptides in power form.

Dissolution
The dissolution of the peptide was necessary for the purification using
chromatography. Various solutions were used in order to attempt dissolution. If
unsuccessful, the samples were lyophilized, then dissolved in other solutions.

Purification
Using High-Performance Liquid Chromatography (HPLC), the peptide was
purified using a peptide method which was composed of a gradient using first Solvent A
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(95% HPLC Grade Water, 5% Acetonitrile, 0.1% trifluoroacetic acid), then Solvent B
(95% Acetonitrile, 5% HPLC Grade Water, 0.1% trifluoroacetic acid), with increasing
Solvent B from 0% to 40% over 25 minutes, regardless of the method. In order to analyze
a peptide, 40 microliters was injected. The peaks were collected based on absorbance,
and these peaks contained the peptides produced in the sythesis.

Mass Spectrometry
A Microflex MALDI-ToF MS (mass spectrometry) was performed in order to
analyze the purified peptide collected from the HPLC. All fractions were analyzed with a
matrix composed of α-cyano-4-hydroxycinnamic acid in standard solution (50%
acetonitrile, 47.5% DI water, and 2.75% trifluoroacetic acid).

Circular Dichroism
A. NF-κB Hybrid
Circular dichroism was performed in order to analyze the secondary structure of
the peptide mimics. The samples were prepared using 50µL of peptide with 200µL of 10
mM Na2HPO4, 100 mM NaCl, pH 7.2. Peptides were analyzed at temperature 25ºC with
a wavelength range of 190-260nm.
B. Metal-Ligand Complexes
Circular dichroism titrations were performed in order to detect if there were
changes in secondary structure of the 250 ng/µL calf thymus DNA upon metal complex
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binding. The samples were prepared using 70 µL of calf thymus DNA with 200 µL of 10
mM Na2HPO4 pH 7.4. The metal-ligand complexes were titrated into the DNA using 1µL
aliquots. All titrations were completed at 25ºC from 220-340nm.

UV-Vis Fluorescence Binding Study
A binding study was conducted using UV-vis fluorescence. Each sample was
prepared with a consistent peptide concentration (8 µM), an increasing DNA
concentration (0-60 µM), and 10 mM Na2HPO4, 100 mM NaCl, pH 7.3. Total sample
volume was equal to 800 µL with 20 samples total. The parameters were the following:
Slit width in 5, out 2.5, wavelength 300-500 nm. The excitation wavelength was set to
297 nm and the emission was 348 nm.

Results
NF-κB Hybrid Peptide Data
Mass Spectrometry
Using MALDI-ToF, mass spectrometry was completed in order to verify the
peptide’s mass after the synthesis, cleavage, and purification. The purification process
involved desalting the peptide using a desalting column in order to remove any salts from
the peptide. Mass spectrometry identified the peptide fraction which correlated to the
theoretical mass. The data shown in Figure 5 shows a highly purified peptide with the
experimental value of 2361.93. NF-κB Hybrid has a theoretical mass of 2360.25.
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Figure 5. Mass spectrometry of NF-κB Hybrid Fractions 2, 3. The graph shows a high
peak at 2361.93 and expected mass is 2360.25.

Circular Dichroism Analysis
Circular dichroism was completed on the peptide mimic, NF-κB Hybrid, in order to
determine the secondary structure. NF-κB Hybrid has the desired structure of the NF-κB
protein binding site, a β-sheet, as shown by the 210 nm minimum, and some random coil,
as shown by the minimum at 195 nm. This secondary structure could be an indicator to
the binding capability of NF-κB Hybrid. Previous research has shown that structured
peptides bind single stranded DNA better that unstructured peptides.8 This study will
investigate if this is true for a dsDNA binding by transcription factors.
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Figure 6. Circular dichroism spectrum of NF-κB Hybrid that shows two minima which
indicate a β-sheet (210 nm) with random coil (195nm). The sample was analyzed at 25ºC
from 190-260 nm in 10 mM Na2HPO4, 100 mM NaCl, and pH 7.2

Fluorescence DNA Binding Study
Fluorescence binding studies were completed in duplicate on NF-κB Hybrid using
various DNA sequences. The concentrations of the peptide and DNA were determined
using UV-vis (Table 1) and were used to calculate volumes for each sample analyzed.
The peptide concentration was kept constant at 8 μM, while the DNA concentration
increased from 0-60 μM (Tables 2, 3, and 4). When the peptide binds DNA, the spectra
shows a decrease. As the DNA concentration increases, there is a greater shift in the
spectra, as shown by Figures 7 and 8.
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Table 1. Fluorescence stock stock solution concentrations in the three trials with NF-κB
Hybrid using three different DNA sequences: κB, Unmethylated, and Methylated.

Peptide
Concentration
DNA Concentration
DNA Sequence

Trial 1

Trial 2

Trial 3

395 μM

339 μM

228 μM

685 μM

575 μM

732 μM

κB Sequence

Unmethylated

Methylated

5’-GGAGTGTCCC-3’

5’-GTATCCGGATAC-3’

5’-GTATC/Me-dC/GGATAC-3’

3’-CCTCACAGGG-5’ 3’-CATAGGCCTATG-5’

3’-CATAGGC/Me-dC/TATG-5’

Table 2. Fraction concentrations for the fluorescence binding study of NF-κB Hybrid and
the κB DNA sequence. Each fraction was run in duplicate in the study.

Sample
1
2
3
4
5
6
7
8
9
10

Fluorescence Concentration Chart
Buffer (μL) Peptide (8μM) DNA (μM)
779
21
0
777
21
2
773
21
5
767
21
10
761
21
15
756
21
20
750
21
25
744
21
30
732
21
40
709
21
60

DNA (μL)
0
2
6
12
18
23
29
35
47
70
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Table 3. Fraction concentrations for the fluorescence binding study of NF-κB Hybrid and
the Unmethylated DNA sequence. Each fraction was run in duplicate in the study.

Sample
1
2
3
4
5
6
7
8
9
10

Fluorescence Concentration Chart
Buffer (μL) Peptide (8μM) DNA (μM)
781
19
0
778
19
2
774
19
5
767
19
10
760
19
15
753
19
20
746
19
25
739
19
30
725
19
40
698
19
60

DNA (μL)
0
3
7
14
21
28
35
42
56
83

Table 4. Fraction concentrations for the fluorescence binding study of NF-κB Hybrid and
the Methylated DNA sequence. Each fraction was run in duplicate in the study.

Sample
1
2
3
4
5
6
7
8
9
10

Fluorescence Concentration Chart
Buffer (μL) Peptide (8μM) DNA (μM)
772
28
0
770
28
2
767
28
5
761
28
10
756
28
15
750
28
20
745
28
25
739
28
30
728
28
40
706
28
60

DNA (μL)
0
2
5
11
16
22
27
33
44
66

14

Figure 7. Fluorescence binding study which shows the binding activity between 8 μM
NF-κB Hybrid and 0-60 μM kB DNA, sequence found in Table 1. The experiment was
completed using 10 mM Na2HPO4, 100 mM NaCl, and pH 7.3.

Figure 8. Fluorescence binding study which shows the binding activity between 8 μM
NF-κB Hybrid and 0-60 μM Unmethylated DNA, sequence found in Table 1. The
experiment was completed using 10 mM Na2HPO4, 100 mM NaCl, and pH 7.3.
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Figure 9. Fluorescence binding study which shows the binding activity between 8 μM
NF-κB Hybrid and 0-60 μM Methylated DNA, sequence found in Table 1. The
experiment was completed using 10 mM Na2HPO4, 100 mM NaCl, and pH 7.3.

Metal-Ligand Complexes Data
The metal-ligand complexes were analyzed using circular dichroism in order to
identify binding between the metal-ligand complex and calf thymus DNA. When binding
occurred, there was an apparent shift down in the spectra showing a change in the
structure of the DNA. The initial shift in CD spectra indicated the binding affinity of each
metal-ligand complex.
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Figure 10. CD Titration of 3 mM Gd-Ligand Complex in 250 ng/µL Calf Thymus DNA
showing a decrease in the DNA signal, which indicates binding activity.
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Figure 11. CD Titration of 3 mM Tb-Ligand Complex in 250 ng/µL Calf Thymus DNA
showing a decrease in the DNA signal, which indicates binding activity.
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CD vs Wavelength
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Figure 12. CD Titration of 3 mM Dy-Ligand Complex in 250 ng/µL Calf Thymus DNA
showing a decrease in the DNA signal, which indicates binding activity.
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Figure 13. CD Titration of 3 mM Ho-Ligand Complex in 250 ng/µL Calf Thymus DNA
showing a decrease in the DNA signal, which indicates binding activity.
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Figure 13. CD Titration of 3 mM Er-Ligand Complex in 250 ng/µL Calf Thymus DNA
showing a decrease in the DNA signal, which indicates binding activity.

Discussion and Conclusion
Binding studies are an important method in which DNA binding molecules can be
analyzed. The binding studies conducted within this research have shown that various
DNA binding molecules can be analyzed using different methods and provide fruitful
results. The fluorescence binding study shows that the NF-κB Hybrid is successful at
binding the κB sequence and a methylated DNA sequence as well. The CD titration
analysis showed that the lanthanide metal-ligand complexes successfully bind calf
thymus DNA.
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There is an abundance of future work which can be completed with this data. To
start, more NF-κB mimics could be synthesized with different binding sequences in order
to determine if there are more peptide mimics which can bind selectively. Additionally,
the dissociation constant, Kd, can be found for the peptide mimics in order to be
compared to the known Kd of the NF-κB protein. The metal-ligand complexes could be
further analyzed by completing a gel electrophoresis assay. In the assays, the desired
result will be a decrease in the amount of relaxed and supercoiled DNA in comparison to
the control as the metal-ligand complex binds. Overall, this research explores the
possibility that altering the expression of genes with organic and inorganic compounds
can one day leads to a decrease in some diseases.
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